Drug Master Files for Bulk Antibiotic Drug Substances: Guidance for Industry
Detailed guidance document from FDA and regulatory agencies.
Document Details
Guidance Document
November 29, 1999
April 28, 2020
2638fcb2-869c-4214-8f7d-6403c9f7b75e
Related Documents
Repeal of Section 507 of the Federal Food, Drug and Cosmetic Act _1
Guidance DocumentJune 15, 1998Center for Drug Evaluation and Research
Extended Release Oral Dosage Forms: Development, Evaluation, and Application of In Vitro/In Vivo Correlations
Guidance DocumentSeptember 1, 1997Center for Drug Evaluation and Research
Alternate Source of the Active Pharmaceutical Ingredient in Pending ANDAs: Guidance for Industry
Guidance DocumentDecember 1, 2000Center for Drug Evaluation and Research
Quick Actions
Transform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox